Lowering Drug Costs through Transparency and Competition
ACHP proposes bold reforms aimed at lowering drug costs by promoting transparency, competition and innovation.
ACHP proposes bold reforms aimed at lowering drug costs by promoting transparency, competition and innovation.
ACHP’s bipartisan policy recommendations will help hold drug makers accountable and curb exorbitantly high drug costs.
ACHP proposes changes to the FEHB Plan Comparison Tool to help federal employees choose the best coverage and improve the shopping experience.
In this issue brief, ACHP has explores how the U.S. health system can develop and expand its primary care system.
February 11, 2020 Navigating the U.S. health care system is unnecessarily complex and prohibitively expensive. And every day consumers are forced to spend more of their own money on care—usually without basic cost and quality information. ACHP proposes a “seal of approval” for the price transparency tools that provide consumers timely accurate and relevant information.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.